Thailand’s Ministry of Public Well being is working with the Nationwide Most cancers Middle Hospital (NCCH), below the Nationwide Most cancers Institute, in Japan, to hold out two most cancers analysis tasks in Thailand, specifically the “Asian Most cancers Trials Community (ATLAS),” which is a drug growth and genomic medication challenge for prognosis and prognosis, and “Decentralized Medical Trials (DCT),” which research the remedy of most cancers sufferers by way of telemedicine, offering long-distance remedy by specialist docs from Japan.
The NCCH additionally operates related tasks in numerous international locations and territories in Asia, equivalent to Malaysia, the Philippines, Indonesia, Vietnam, Singapore, and Taiwan. Nonetheless, Thailand has been chosen as the middle of analysis operations. Thailand shall be a manufacturing base for most cancers medication, derived from the analysis, with a purpose to distribute them in Asia.
Presently, the NCCH has arrange a coordination heart to drive the tasks in Bangkok since early November 2022. Executives from the NCCH visited Bangkok and held discussions with Thailand’s public well being companies to arrange the challenge. (PRD)
